Establishing Global Reference Values for Human Milk
MILQ
1 other identifier
observational
2,000
4 countries
4
Brief Summary
The primary purpose of the proposed research is to establish Reference Values (RVs) for micronutrients (MN) and macronutrients in human milk. The investigators' research to date has revealed highly variable milk MN concentrations among populations, and very low values in some low income countries (LICs) likely caused by poor maternal status and/or diet but RVs are needed to interpret these values. During the past year the investigators conducted a review of human milk nutrient composition, and formed a Technical Advisory Group (TAG) which developed the current proposal. Here, the investigators are conducting a longitudinal project on well-nourished women and infants. The Mothers, Infants and Lactation Quality (MILQ) study is a multi-center cohort project, investigating breast milk nutrient composition in well-nourished women across the first 8.5 months of lactation in four different populations. The countries involved are Denmark, Brazil, Bangladesh and The Gambia. Exclusive breastfeeding is an eligibility criterion up until the second post-partum study visit (between 1 - 3.4 months postpartum), with the exception of the first week after delivery. Other data collected on mothers and infants, including maternal and infant nutrient intake and status, morbidity, milk volume, and infant development, will inform interpretation and support application of the results. While the priority is to develop RVs for MN, other analyses will include human milk oligosaccharides (HMOs) and proteins, and free amino acids (FAA) in infant plasma. Thus, with the samples obtained the investigators will perform (a) laboratory analyses of milk, plasma and urine nutrients to construct RVs for global application, (b) analyses of HMOs and proteins in milk, and (c) metabolomic analysis of FAA and other metabolites in infant plasma. By request of the Bill and Melinda Gates Foundation (BMGF), colostrum and fecal microbiota samples will also be collected and stored for later analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2017
CompletedFirst Posted
Study publicly available on registry
August 18, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedJuly 7, 2021
July 1, 2021
4.2 years
August 3, 2017
July 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in vitamin and mineral concentrations in human breast milk
To establish reference values, the vitamin and mineral concentrations will be measured in milk of well-nourished women
Breast milk samples collected 1-3.4, 3.5-5.9, and 6-8.5 months postpartum
Secondary Outcomes (27)
Variation in other constituents of human breast milk
Breast milk samples collected at 1-3.4, 3.5-5.9, and 6-8.5 months postpartum
Micronutrient status of mothers and infants
Blood and urine samples surveyed at 1-3.4, 3.5-5.9, and 6-8.5 months postpartum
Milk volume
1-3.4, 3.5-5.9, and 6-8.5 months postpartum
Maternal and infant iodine status
1-3.4, 3.5-5.9, and 6-8.5 months postpartum
Milk iodine
1-3.4, 3.5-5.9, and 6-8.5 months postpartum
- +22 more secondary outcomes
Study Arms (4)
Bangladesh
Assessment of human milk nutrient composition. Approximately 500 women and their infants recruited, 250 dyads completing study
Brazil
Assessment of human milk nutrient composition. Approximately 500 women and their infants recruited, 250 dyads completing study
Denmark
Assessment of human milk nutrient composition. Approximately 500 women and their infants recruited, 250 dyads completing study
The Gambia
Assessment of human milk nutrient composition. Approximately 500 women and their infants recruited, 250 dyads completing study
Interventions
Observational study to measure nutrients in human milk during lactation and their relationship to maternal and infant nutritional status.
Eligibility Criteria
Well-nourished pregnant women in the third trimester of pregnancy at recruitment, then lactating with their infant from 1-8.5 months postpartum.
You may qualify if:
- No vitamin-mineral supplements during third trimester of pregnancy or during lactation except for iron + folic acid, also vitamin D and Ca in Denmark.
- Low habitual intake of highly-fortified foods (iodized salt excepted).
- No relevant past or current medical problems including gestational diabetes or pre-eclampsia.
- Singleton delivery, not preterm.
- BMI ≥18.5 to \<30.0 kg/m2, height ≥150 cm.
- Mid-upper arm circumference (MUAC) ≥23 and ≤33 cm in pregnancy
- Consuming a nutritionally adequate diet i.e. not vegan or macrobiotic, ≥5 food groups/d each ≥15g. At screening this information will be collected with a locally-appropriate and validated food frequency questionnaire.
- Non-anemic in pregnancy (Hb \>100 g/L)
- Alcohol intake ≤5 units (50 mL pure alcohol)/week.
- Non-smoker.
- Birth weight 2500-4200 g, 37-42 weeks of gestation.
- No congenital malformations that interfere with feeding or growth and development.
You may not qualify if:
- Cessation of or non-exclusive breastfeeding.
- Serious maternal illness.
- Infant length-for-age, weight-for-age or weight-for-length \< -2 Z.
- Cessation of breastfeeding.
- Serious maternal illness.
- Infant length-for-age, weight-for-age or weight-for-length \< -2 Z.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- USDA, Western Human Nutrition Research Centerlead
- University of Copenhagencollaborator
- Medical Research Council Unit, The Gambiacollaborator
- International Centre for Diarrhoeal Disease Research, Bangladeshcollaborator
- Universidade Federal do Rio de Janeirocollaborator
- Bill and Melinda Gates Foundationcollaborator
Study Sites (4)
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Dhaka, 1212, Bangladesh
Federal University of Rio de Janeiro
Rio de Janeiro, RJ21941-590, Brazil
University of Copenhagen
Copenhagen, Frederiksberg, 1958, Denmark
Medical Research Council Gambia
Bakau, Kombo Saint Mary's, The Gambia
Related Publications (3)
Christensen SH, Rom AL, Greve T, Lewis JI, Frokiaer H, Allen LH, Molgaard C, Renault KM, Michaelsen KF. Maternal inflammatory, lipid and metabolic markers and associations with birth and breastfeeding outcomes. Front Nutr. 2023 Sep 4;10:1223753. doi: 10.3389/fnut.2023.1223753. eCollection 2023.
PMID: 37731394DERIVEDChristensen SH, Lewis JI, Larnkjaer A, Frokiaer H, Allen LH, Molgaard C, Michaelsen KF. Associations between maternal adiposity and appetite-regulating hormones in human milk are mediated through maternal circulating concentrations and might affect infant outcomes. Front Nutr. 2022 Nov 4;9:1025439. doi: 10.3389/fnut.2022.1025439. eCollection 2022.
PMID: 36407523DERIVEDAllen LH, Hampel D, Shahab-Ferdows S, Andersson M, Barros E, Doel AM, Eriksen KG, Christensen SH, Islam M, Kac G, Keya FK, Michaelsen KF, de Barros Mucci D, Njie F, Peerson JM, Moore SE. The Mothers, Infants, and Lactation Quality (MILQ) Study: A Multi-Center Collaboration. Curr Dev Nutr. 2021 Sep 20;5(10):nzab116. doi: 10.1093/cdn/nzab116. eCollection 2021 Oct.
PMID: 34712893DERIVED
Biospecimen
Breast milk, blood, saliva, urine and feces
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsay H Allen, PhD
USDA/WHNRC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2017
First Posted
August 18, 2017
Study Start
September 1, 2017
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
July 7, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share
Individual participants data will only be available as de-identified data.